21 USC 399f - Ensuring adequate information regarding pharmaceuticals for all populations, particularly underrepresented subpopulations, including racial subgroups

U.S Code last checked for updates: Nov 22, 2024

§ 399f.

Ensuring adequate information regarding pharmaceuticals for all populations, particularly underrepresented subpopulations, including racial subgroups

(a)

Communication plan

(b)

Content

The communication plan described under subsection (a)—

(1)

shall take into account—

(A)

the goals and principles set forth in the Strategic Action Plan to Reduce Racial and Ethnic Health Disparities issued by the Department of Health and Human Services;

(B)

the nature of the medical product; and

(C)

health and disease information available from other agencies within such Department, as well as any new means of communicating health and safety benefits and risks related to medical products;

(2)

taking into account the nature of the medical product, shall address the best strategy for communicating safety alerts, labeled indications for the medical products, changes to the label or labeling of medical products (including black-box warnings, health advisories, health and safety benefits and risks), particular actions to be taken by health care professionals and patients, any information identifying particular subpopulations, and any other relevant information as determined appropriate to enhance communication, including varied means of electronic communication; and

(3)

shall include a process for implementation of any improvements or other modifications determined to be necessary.

(c)

Issuance and posting of communication plan

(1)

Communication plan

(2)

Posting of communication plan on the office of minority health web site

(Pub. L. 112–144, title XI, § 1138, July 9, 2012, 126 Stat. 1125.)

cite as: 21 USC 399f